AI Revolutionizing Drug Development and Financial Collapse

41sec Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Venture capitalists have invested $18 billion in AI biotech startups over the past decade, leading to the development of about two dozen drugs currently undergoing clinical trials. The outcome of these trials will determine the impact of AI in drug development. Additionally, a criminal racketeering trial involving Bill Hwang commenced, focusing on the collapse of Archigos Capital Management, a family office and hedge fund founded by Hwang that experienced a rapid rise and fall in wealth.

Episode 319: Neal and Toby discuss the big discovery from Google’s DeepMind using AI to potentially produce new drugs not possible by mere humans. Then, the biggest ‘pump and brag scheme’ that shook Wall Street goes to trial. Next, a new report shows renewable energy sources making progress towards a big clean energy goal. Also, Neal shares his favorite numbers covering FTX refunds, job satisfaction, and Taylor Swift. Lastly, an upheaval is bubbling in Germany over a food staple: doner kebabs

Visit https://www.wendys.com/morningbrew for more!

00:00 - Apple ad controversy

3:00 - AI takes on drug industry

7:45 - Archegos goes to trial

11:30 - Renewable energy milestone

15:00 - FTX refund

17:30 - American workers happy-ish

19:15 - Taylor Swift takes over Europe

21:30 - Kebab-flation in Germany

Per My Last Email: Spotify, Apple, YouTube or wherever you listen to podcasts

Get your Morning Brew Daily Mug HERE: https://shop.morningbrew.com/products/morning-brew-daily-mug?utm_medium=youtube&utm_source=mbd&utm_campaign=mug

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD